Sign in
4

Changes in Ownership

Protara Therapeutics, Inc. Filed Acc 0001209191-21-006571

Options or other derivatives

  • Director acquired 21,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Smith Cynthia Director 2021-01-29 Grant or award · Stock Option (Right to Buy) +18,000 18,000 D: show line 1 in the form
Smith Cynthia Director 2021-01-29 Grant or award · Stock Option (Right to Buy) +3,750 21,750 D: show line 2 in the form
Loading xslF345X03/doc4.xml…